3 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, Hemic and Lymphatic Diseases, Infant, Newborn, Diseases, blood platelet disease, hematologic disorder, neonatal thrombocytopenia, thrombocytopeniaRecruitingPhase 32026-09-25NCT06533098
A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, Hemic and Lymphatic Diseases, Infant, Newborn, Diseases, blood platelet disease, hematologic disorder, neonatal thrombocytopenia, thrombocytopeniaRecruitingPhase 32026-09-25NCT06449651
The Neonatal Hemorrhagic Risk Assessment in ThrombocytopeniaCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Infant, Newborn, Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, blood platelet disease, hematologic disorder, neonatal thrombocytopenia, thrombocytopeniaRecruitingNot stated2024-10-09NCT04598750